Empowered Funds LLC Decreases Position in The Procter & Gamble Company (NYSE:PG)

Empowered Funds LLC decreased its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 0.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 138,991 shares of the company’s stock after selling 261 shares during the period. Empowered Funds LLC’s holdings in Procter & Gamble were worth $24,073,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Legal & General Group Plc grew its holdings in shares of Procter & Gamble by 0.6% during the second quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock worth $3,567,556,000 after purchasing an additional 122,190 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Procter & Gamble by 8.2% in the second quarter. Dimensional Fund Advisors LP now owns 9,691,925 shares of the company’s stock worth $1,598,510,000 after buying an additional 733,440 shares in the last quarter. Janus Henderson Group PLC lifted its holdings in shares of Procter & Gamble by 1.3% in the 1st quarter. Janus Henderson Group PLC now owns 6,008,938 shares of the company’s stock worth $974,914,000 after acquiring an additional 79,665 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its position in Procter & Gamble by 1.3% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 5,716,799 shares of the company’s stock valued at $990,150,000 after buying an additional 72,851 shares during the period. Finally, Canada Pension Plan Investment Board grew its stake in shares of Procter & Gamble by 3.9% during the second quarter. Canada Pension Plan Investment Board now owns 5,706,199 shares of the company’s stock valued at $941,066,000 after buying an additional 216,300 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In related news, CEO Jon R. Moeller sold 37,240 shares of the firm’s stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the sale, the chief executive officer now owns 263,537 shares in the company, valued at approximately $44,508,763.93. This trade represents a 12.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Shailesh Jejurikar sold 10,623 shares of the company’s stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $1,797,624.06. Following the completion of the transaction, the chief operating officer now directly owns 23,890 shares of the company’s stock, valued at $4,042,665.80. The trade was a 30.78 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 313,597 shares of company stock valued at $53,268,499 in the last ninety days. Corporate insiders own 0.18% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Jefferies Financial Group lowered Procter & Gamble from a “buy” rating to a “hold” rating and decreased their target price for the stock from $182.00 to $175.00 in a research report on Wednesday, July 24th. Piper Sandler began coverage on Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price objective for the company. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a research note on Monday, September 30th. Nine equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.

Read Our Latest Stock Analysis on PG

Procter & Gamble Stock Up 0.1 %

Shares of PG opened at $167.27 on Friday. The business’s 50 day simple moving average is $170.61 and its 200-day simple moving average is $168.28. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94. The stock has a market capitalization of $393.93 billion, a price-to-earnings ratio of 28.81, a price-to-earnings-growth ratio of 3.60 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm’s revenue was down .6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.83 EPS. As a group, equities analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.41%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s payout ratio is presently 69.48%.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.